PIK3CA and neoplasm: Because p85α inhibits PI3K activity, we hypothesized that the dysfunctional PIK3R1-CCDC178 fusion protein could promote activation of the PI3K-AKT-mTOR signaling cascade and further promote tumor growth, invasiveness, and drug resistance.